The DOI matches its Crossref record; 247 of the 247 references it cites were found in a registry or an index.
Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson’s Disease
Open accessAbstract
Parkinson’s disease (PD) is the second most common neurodegenerative disease, the main pathological hallmark of which is the accumulation of α-synuclein (α-syn) and the formation of filamentous aggregates called Lewy bodies in the brainstem, limbic system, and cortical areas. Lipidomics is a newly emerging field which can provide fresh insights and new answers that will enhance our capacity for early diagnosis, tracking disease progression, predicting critical endpoints, and identifying risk in pre-symptomatic persons. In recent years, lipids have been implicated in many aspects of PD pathology. Biophysical and lipidomic studies have demonstrated that α-syn binds preferentially not only to specific lipid families but also to specific molecular species and that these lipid-protein complexes enhance its interaction with synaptic membranes, influence its oligomerization and aggregation, and interfere with the catalytic activity of cytoplasmic lipid enzymes and lysosomal lipases, thereby affecting lipid metabolism. The genetic link between aberrant lipid metabolism and PD is even more direct, with mutations in GBA and SMPD1 enhancing PD risk in humans and loss of GALC function increasing α-syn aggregation and accumulation in experimental murine models. Moreover, a number of lipidomic studies have reported PD-specific lipid alterations in both patient brains and plasma, including alterations in the lipid composition of lipid rafts in the frontal cortex. A further aspect of lipid dysregulation promoting PD pathogenesis is oxidative stress and inflammation, with proinflammatory lipid mediators such as platelet activating factors (PAFs) playing key roles in arbitrating the progressive neurodegeneration seen in PD linked to α-syn intracellular trafficking. Lastly, there are a number of genetic risk factors of PD which are involved in normal lipid metabolism and function. Genes such as PLA2G6 and SCARB2, which are involved in glycerophospholipid and sphingolipid metabolism either directly or indirectly are associated with risk of PD. This review seeks to describe these facets of metabolic lipid dysregulation as they relate to PD pathology and potential pathomechanisms involved in disease progression, while highlighting incongruous findings and gaps in knowledge that necessitate further research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–247 of 247
Farmer, K., Smith, C. A., Hayley, S. P., & Smith, J. C. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160818865 · Cited by 78
Gündner, A. L., Durán-Pacheco, G., Zimmermann, S., Ruf, I., Moors, T. E., Baumann, K., Jagasia, R., van de Berg, W. D. J., & Kremer, T. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.09.015 · Cited by 78
Cunningham, T. J., Yao, L., & Lucena, A. (2008) · Journal of Inflammation · doi:10.1186/1476-9255-5-17 · Cited by 77
Molecular Insights into the Interaction between α-Synuclein and Docosahexaenoic Acid
Franceschi, G. D., Frare, E., Bubacco, L., Mammi, S., Fontana, A., & de Laureto, P. P. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.09.008 · Cited by 74
Pasquale, E. D., Fantini, J., Chahinian, H., Maresca, M., Taïeb, N., & Yahi, N. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.01.046 · Cited by 71
Lue, L., Walker, D. G., Adler, C. H., Shill, H. A., Tran, H. T., Akiyama, H., Sue, L. I., Caviness, J. N., Sabbagh, M. N., & Beach, T. G. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2012.00585.x · Cited by 69
Phospholipase D1 regulates autophagic flux and clearance of α-synuclein aggregates
Bae, E.-J., Lee, H.-J., Jang, Y.-H., Michael, S., Masliah, E., Min, D. S., & Lee, S. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.30 · Cited by 69
Manzoni, C., & Lewis, P. A. (2013) · The FASEB Journal · doi:10.1096/fj.12-223842 · Cited by 69
Gorbatyuk, O. S., Li, S., Nguyen, F. N., Manfredsson, F. P., Kondrikova, G., Sullivan, L. F., Meyers, C., Chen, W., Mandel, R. J., & Muzyczka, N. (2010) · Molecular Therapy · doi:10.1038/mt.2010.137 · Cited by 67
Potentiation of neurotoxicity in double-mutant mice with Pink1 ablation and A53T-SNCA overexpression
Gispert, S., Brehm, N., Weil, J., Seidel, K., Rüb, U., Kern, B., Walter, M. J., Roeper, J., & Auburger, G. W. J. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu520 · Cited by 67
Tariq, M., Khan, H. A., Moutaery, K. A., & Deeb, S. A. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00427-5 · Cited by 66
Statin Use and the Risk of Parkinson's Disease: An Updated Meta-Analysis
Bai, S., Song, Y., Huang, X., Peng, L., Jia, J., Liu, Y., & Lu, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152564 · Cited by 66
Wei, J., Fujita, M., Nakai, M., Waragai, M., Sekigawa, A., Sugama, S., Takenouchi, T., Masliah, E., & Hashimoto, M. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080680 · Cited by 65
Shield, A., Murray, T. P., & Philip G. Board (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.06.189 · Cited by 64
Bauldry, S. A., Elsey, K. L., & Bass, D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74017-4 · Cited by 63
Parkinson’s disease: From human genetics to clinical trials
van der Brug, M. P., Singleton, A., Gasser, T., & Lewis, P. A. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa8280 · Cited by 62
The contribution of Niemann-Pick SMPD1 mutations to Parkinson disease in Ashkenazi Jews
Dagan, E., Schlesinger, I., Ayoub, M., Mory, A., Nassar, M., Kurolap, A., Peretz-Aharon, J., & Gershoni‐Baruch, R. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.06.016 · Cited by 59
Lipid profiling of parkin‐mutant human skin fibroblasts
Lobasso, S., Tanzarella, P., Vergara, D., Maffia, M., Cocco, T., & Corcelli, A. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25815 · Cited by 58
Narayanan, V. S., Guo, Y., & Scarlata, S. (2004) · Biochemistry · doi:10.1021/bi0487140 · Cited by 57
Parkinson Disease: Research Update and Clinical Management
Fritsch, T., Smyth, K. A., Wallendal, M. S., Hyde, T., Leo, G. J., & Geldmacher, D. (2012) · Southern Medical Journal · doi:10.1097/smj.0b013e318273a60d · Cited by 56
Shim, J. H., Yoon, S. H., Kim, K., Han, J., Ha, J., Hyun, D. H., Paek, S. H., Kang, U. J., Zhuang, X., & Son, J. H. (2011) · Mitochondrion · doi:10.1016/j.mito.2011.05.013 · Cited by 55
Decreased Cholesterol Biosynthesis in Fibroblasts from Patients with Parkinson Disease
Musanti, R., Parati, E. A., Lamperti, E., & Ghiselli, G. (1993) · Biochemical Medicine and Metabolic Biology · doi:10.1006/bmmb.1993.1016 · Cited by 54
α-Synuclein Oligomers Induced by Docosahexaenoic Acid Affect Membrane Integrity
Fecchio, C., Franceschi, G. D., Relini, A., Greggio, E., Serra, M. D., Bubacco, L., & de Laureto, P. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082732 · Cited by 53
Glucocerebrosidase deficits in sporadic Parkinson disease
Murphy, K. E., & Halliday, G. M. (2014) · Autophagy · doi:10.4161/auto.29074 · Cited by 53
Redenšek, S., Trošt, M., & Dolžan, V. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00020 · Cited by 52
Role of Phosphoinositides at the Neuronal Synapse
Frère, S. G. A., Chang-Ileto, B., & Paolo, G. D. (2012) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-3015-1_5 · Cited by 49
Upregulation of α-synuclein in neurons and glia in inflammatory demyelinating disease
Papadopoulos, D., Ewans, L., Pham-Dinh, D., Knott, J., & Reynolds, R. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.01.007 · Cited by 49
Parkin disease and the Lewy body conundrum
Doherty, K. A., & Hardy, J. (2013) · Movement Disorders · doi:10.1002/mds.25486 · Cited by 47
Cheng, S., & Trombetta, L. D. (2003) · Toxicology Letters · doi:10.1016/j.toxlet.2003.09.009 · Cited by 47
Biomarkers of Parkinson's disease and Dementia with Lewy bodies
Henchcliffe, C., Dodel, R. C., & Beal, M. F. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.09.002 · Cited by 45
SREBF1 links lipogenesis to mitophagy and sporadic Parkinson disease
Ivatt, R. M., & Whitworth, A. J. (2014) · Autophagy · doi:10.4161/auto.29642 · Cited by 45
Schneider, J. S., Kean, A., & DiStefano, L. M. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490420113 · Cited by 42
Gangliosides help stabilize the brain
Proia, R. L. (2004) · Nature Genetics · doi:10.1038/ng1104-1147 · Cited by 41
Glucocerebrosidase haploinsufficiency in A53T α-synuclein mice impacts disease onset and course
Tayebi, N., Parisiadou, L., Berhe, B. A., Gonzalez, A. N., Serra‐Vinardell, J., Tamargo, R., Maniwang, E., Sorrentino, Z. A., Fujiwara, H., Grey, R. J., et al. (2017) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2017.11.001 · Cited by 40
Lipid metabolism alterations in the neuronal response to A53T α-synuclein and Fe-induced injury
Campos, S. S., Alza, N. P., & Salvador, G. A. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.08.007 · Cited by 40
Evidence That α-Synuclein Does Not Inhibit Phospholipase D
Rappley, I., Gitler, A. D., Selvy, P. E., LaVoie, M. J., Levy, B. D., Brown, H. A., Lindquist, S. L., & Selkoe, D. J. (2009) · Biochemistry · doi:10.1021/bi801871h · Cited by 39
Kim, B. K., Shin, E., Kim, H., Chung, Y. H., Dang, D.-K., Jung, B.-D., Park, D.-H., Wie, M., Kim, W.-K., Shimizu, T., et al. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.05.010 · Cited by 35
Brekk, O. R., Moskites, A., Ole Isacson, A., & Hallett, P. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-33474-z · Cited by 34
Clark, L. N., Kisselev, S., Park, N., Ross, B., Verbitsky, M., Rios, E., Alcalay, R. N., Lee, J. H., & Louis, E. D. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.05.008 · Cited by 32
Schlossmacher, M. G., Tomlinson, J. J., dos Santos, G. M., Shutinoski, B., Brown, E. G., Manuel, D. G., & Mestre, T. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13476 · Cited by 31
Conde, M. A., Alza, N. P., González, P. A. I., Bilbao, P., Campos, S. S., Uranga, R. M., & Salvador, G. A. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.03.006 · Cited by 31
Riedel, M. J., Goldbaum, O., Wille, M., & Richter‐Landsberg, C. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9439-5 · Cited by 26
Yoshinaga, N., Yasuda, Y., Murayama, T., & Nomura, Y. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02340-9 · Cited by 25
Schneider, J. S., & DiStefano, L. M. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00015-x · Cited by 21
Parkinson’s Disease: A Traffic Jam?
Clague, M. J., & Rochin, L. (2016) · Current Biology · doi:10.1016/j.cub.2016.03.001 · Cited by 16
Nuclear expression of diacylglycerol kinases: possible involvement in DNA replication.
Evangelisti, C., Bortul, R., Tabellini, G., Papa, V., Cocco, L., & Martelli, A. M. (2006) · PubMed · doi:10.4081/969 · Cited by 12
(2000) · doi:10.1002/1097-4547(20001001)62:1<9::aid-jnr2>3.0.co;2-u
Cited by
Ageing as a risk factor for neurodegenerative disease
Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S. G., Croteau, D. L., & Bohr, V. A. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0244-7 · Cited by 3,310
Brain lipidomics: From functional landscape to clinical significance
Yoon, J. H., Seo, Y., Jo, Y. S., Lee, S., Cho, E., Cazenave-Gassiot, A., Shin, Y.-S., Moon, M. H., An, H. J., Wenk, M. R., et al. (2022) · Science Advances · doi:10.1126/sciadv.adc9317 · Cited by 324
Lipid droplets in the nervous system
Ralhan, I., Chang, C.-L., Lippincott-Schwartz, J., & Ioannou, M. S. (2021) · Journal of Cell Biology · doi:10.1083/jcb.202102136 · Cited by 281
“While alterations in lipid homeostasis are well studied in many neuropathologies (Alecu and Bennett, 2019; Chang and Chang, 2017; Karasinska and Hayden, 2011), the appearance and function of lipid droplets in the brain have only recently gained attention.”
BackgroundPlasma membrane integrity in health and disease: significance and therapeutic potential
Dias, C., & Nylandsted, J. (2021) · Cell Discovery · doi:10.1038/s41421-020-00233-2 · Cited by 278
Probiotic Bacillus subtilis protects against α-synuclein aggregation in C. elegans
Goya, M. E., Xue, F., Sampedro-Torres-Quevedo, C., Arnaouteli, S., Riquelme-Dominguez, L., Romanowski, A., Brydon, J., Ball, K. L., Stanley-Wall, N. R., & Doitsidou, M. (2020) · Cell Reports · doi:10.1016/j.celrep.2019.12.078 · Cited by 205
“We focused on a specific pathway branch of lipid metabolism, the sphingolipid metabolism pathway, as it has been proposed to modify a-syn pathology in PD (Alecu and Bennett, 2019; Galvagnion, 2017; Lin et al., 2019; Plotegher et al., 2019).”
Background
Metadata
- Authors
- Alecu, I., & Bennett, S. A. L.
- Venue
- Frontiers in Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2019-04-11
- Volume
- 13
- Pages
- 328-328
- ISSN
- 1662-453X (ISSN-L)
- OpenAlex
- W2938730938
- Cited by
- 258
- References
- 247
- FWCI
- 15.29
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.